Group 1 - The core point of the article is that Hema Medical (03309) has agreed to transfer 55% of Apollo's total issued share capital back to Mingda Glasses, which involves the cancellation of a debt of 504.9 million RMB [1] - The transaction will relieve the company of all liabilities under the aforementioned bond, indicating a strategic move to optimize internal resource utilization [1] - Following the completion of this transaction, Apollo will no longer be a non-wholly owned subsidiary of the company, and the company will not hold any equity interest in Apollo [1] Group 2 - The company is focusing on strategic initiatives, including enhancing ophthalmic services in Hong Kong and mainland China, as well as dental and medical services in Shenzhen [1] - The sale aligns with the company's strategy to optimize the use of internal resources [1]
希玛医疗(03309)向明达眼镜出售阿波罗55%股权